MSLN and neoplasm: Mesothelin (MSLN) is a glycosylphosphatidylinositol-linked protein [1] that is overexpressed in different tumor types, including ovarian cancer (OC) and mesotheliomas, and variably impacts the patient’s prognosis [2].